---
figid: PMC6767864__fig-2
figlink: pmc/articles/PMC6767864/figure/f2/
number: <b>FIG. 2.</b>
caption: Proposed mechanisms of negative regulation of IFN responses by IFN-λ4. Binding
  of IFN-λ4 to its receptors IFNLR1 and IL10R2 leads to phosphorylation and dimerization
  of STAT1 and STAT2, recruitment of IRF9, and formation of ISGF3 complex. ISGF3 complex
  activates ISRE, leading to expression of multiple ISGs, including USP18 and ISG15.
  SOCS1 expression is also induced by IFN-λ4, although the role of the ISGF3 complex
  in SOCS1 induction is unclear. SOCS1 inhibits the formation of ISGF3 complex by
  inhibiting STAT1 phosphorylation by type III IFNs but to a lesser extent than by
  IFN-α. In contrast, USP18 inhibits binding of JAK1 to IFNAR2, thus reducing the
  effectiveness of IFN-α in activating the JAK/STAT pathway. USP18 also targets ISG15
  for ubiquitination, thus inhibiting the process of ISGlyation. IL10R2, interleukin
  10 receptor 2; ISGs, IFN-stimulated genes; ISRE, interferon-sensitive response element;
  SOCS1, suppressor of cytokine signaling. Color images are available online.
pmcid: PMC6767864
papertitle: 'The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.'
reftext: Olusegun O. Onabajo, et al. J Interferon Cytokine Res. 2019 Oct 1;39(10):636-641.
pmc_ranked_result_index: '23693'
pathway_score: 0.9574932
filename: fig-2.jpg
figtitle: 'IFN-λ4 Conundrum: When a Good Interferon Goes Bad'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6767864__fig-2.html
  '@type': Dataset
  description: Proposed mechanisms of negative regulation of IFN responses by IFN-λ4.
    Binding of IFN-λ4 to its receptors IFNLR1 and IL10R2 leads to phosphorylation
    and dimerization of STAT1 and STAT2, recruitment of IRF9, and formation of ISGF3
    complex. ISGF3 complex activates ISRE, leading to expression of multiple ISGs,
    including USP18 and ISG15. SOCS1 expression is also induced by IFN-λ4, although
    the role of the ISGF3 complex in SOCS1 induction is unclear. SOCS1 inhibits the
    formation of ISGF3 complex by inhibiting STAT1 phosphorylation by type III IFNs
    but to a lesser extent than by IFN-α. In contrast, USP18 inhibits binding of JAK1
    to IFNAR2, thus reducing the effectiveness of IFN-α in activating the JAK/STAT
    pathway. USP18 also targets ISG15 for ubiquitination, thus inhibiting the process
    of ISGlyation. IL10R2, interleukin 10 receptor 2; ISGs, IFN-stimulated genes;
    ISRE, interferon-sensitive response element; SOCS1, suppressor of cytokine signaling.
    Color images are available online.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA4
  - IFNA1
  - IFNA2
  - IFNA5
  - IFNA7
  - IFNA8
  - IFNA17
  - IFNA6
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNAR2
  - IFNLR1
  - TYK2
  - JAK1
  - STAT1
  - IRF9
  - USP18
  - STAT2
  - ISG15
genes:
- word: IFN-A4
  symbol: IFNA4
  source: hgnc_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: IFNA
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: IFNLR1
  symbol: IFNLR1
  source: hgnc_symbol
  hgnc_symbol: IFNLR1
  entrez: '163702'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: USP18
  symbol: USP18
  source: hgnc_symbol
  hgnc_symbol: USP18
  entrez: '11274'
- word: +USP18
  symbol: USP18
  source: hgnc_symbol
  hgnc_symbol: USP18
  entrez: '11274'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: ISG15
  symbol: ISG15
  source: hgnc_symbol
  hgnc_symbol: ISG15
  entrez: '9636'
chemicals: []
diseases: []
---
